Royal Bank of Canada »

Silence Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $36k 1.9k 18.72
2024-06-30 $89k 4.7k 18.94

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Silence Therapeutics

TCG Crossover Management
Siren
Redmile Group
Logos Global Management
Deep Track Capital
Frazier Life Sciences Management
Nextech Invest
Henderson Group
Eventide Asset Management
Cormorant Asset Management
Ikarian Capital
5AM Venture Management
Point72 Asset Management
Citadel Advisors
Woodline Partners

View all funds holding Silence Therapeutics